Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cardiac Marker Market Grown from 2024 to 2025?

In recent times, the cardiac marker market has seen speedy progression in its size. It is projected to surge from $11.26 billion in 2024 to $12.47 billion in 2025, registering a compound annual growth rate (CAGR) of 10.8%. The expansion observed in the historic period can be linked to an escalating prevalence of cardiovascular disorders, senior citizen population and cardiovascular risk factors, awareness drives and health checkups, incorporation of biomarkers into clinical application, along with stiff regulatory norms and guidelines.

What Growth Rate Is Anticipated for the Cardiac Marker Market in the Coming Years?

Over the coming years, substantial expansion is expected in the cardiac marker market size, with projections suggesting it will reach $20.35 billion by 2029, reflecting a compound annual growth rate (CAGR) of 13.0%. Factors contributing to this projected growth during the forecast period include the increasing prevalence of lifestyle-related diseases, advancements in remote monitoring and telemedicine, individualized medicine and precision diagnostics, as well as the adoption of point-of-care testing (POCT). The healthcare industry’s collaborations and partnerships are also seen as driving forces. Predicted trends for the forecast period include the discovery and validation of biomarkers, personalized medicine strategies, advances in assay platform technology, the incorporation of high-sensitivity troponin tests, and a surge in the incidence of cardiovascular diseases.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Who Are the Leading Companies in the Cardiac Marker Market?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

What Are the Key Drivers of the Cardiac Marker Market?

The escalation in heart-related ailments is projected to drive the expansion of the cardiac marker industry. Cardiac illnesses represent a variety of disorders that impact the heart’s structure or function and give rise to multiple medical complications. Cardiac markers serve as a diagnostic tool and a monitoring system for several heart conditions like heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, there has been an upsurge in the demand for these diagnostic tests or cardiac markers. For example, as per the British Heart Foundation, a cardiovascular research charity based in the UK, England witnessed an increase of 30,000 deaths due to coronary heart disease from the onset of the pandemic till August 2022. An astounding 346,000 individuals were recorded on the cardiac waiting list by August 2022. Thus, the growing incidence of heart diseases is anticipated to spur the growth of the cardiac marker market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

What Are the Key Market Segments in the Cardiac Marker Industry?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

What Are the Latest Trends in the Cardiac Marker Market?

The cardiac marker industry is currently experiencing a surge in product innovation trends driven by major market participants’ desire to solidify their standing through unique solutions. As an example, MiRxes, a biotech firm from Singapore, corroborated a microRNA-based diagnostic check for early illness identification in September 2022. Once this test is made commercially available, it will augment MiRxes’ existing assortment of cancer blood tests, thereby providing an extensive array of preliminary detection techniques. This development will help mitigate the escalating clinical and socioeconomic impacts of fatal diseases such as cancer and cardio-pulmonary disorders.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

What Are the Key Regional Markets in the Cardiac Marker Industry?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

This Report Delivers Insight On:

1. How big is the cardiac marker market, and how is it changing globally?

2. Who are the major companies in the cardiac marker market, and how are they performing?

3. What are the key opportunities and risks in the cardiac marker market right now?

4. Which products or customer segments are growing the most in the cardiac marker market?

5. What factors are helping or slowing down the growth of the cardiac marker market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model